Stay updated on Anamorelin HCl in NSCLC-Cachexia Clinical Trial
Sign up to get notified when there's something new on the Anamorelin HCl in NSCLC-Cachexia Clinical Trial page.

Latest updates to the Anamorelin HCl in NSCLC-Cachexia Clinical Trial page
- Check2 days agoChange DetectedThe study locations now list Tel Litwinsky, Israel and no longer include Qiryat Krinitzi, Israel, updating the geographic sites for ROMANA 2 recruitment.SummaryDifference0.1%

- Check9 days agoChange DetectedThe study location list was updated to include Qiryat Krinitzi, Israel and remove Tel Litwinsky, Israel, reflecting changes to participating centers.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a small update to the study record metadata.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedMeSH terms such as Carcinoma, Non-Small-Cell Lung and Cachexia were added to label and categorize the study topics for better discoverability. This change does not alter the study design, outcomes, or eligibility criteria.SummaryDifference57%

- Check38 days agoChange DetectedThe page now displays Revision: v3.6.5, indicating a new build of the site template or backend update. This update is behind-the-scenes and does not modify study content or data presented.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page's revision badge was updated from v3.6.3 to v3.6.4, indicating a small update to the page or its underlying system. There is no indication of changes to the study details or displayed information.SummaryDifference0.0%

Stay in the know with updates to Anamorelin HCl in NSCLC-Cachexia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anamorelin HCl in NSCLC-Cachexia Clinical Trial page.